4 Dividend Stocks That Give You a Clean Taste

Published Mon, 16 Jan 2012 20:23 CET by DividendYields.org

Introduction
Since I like to take good care of my teeth, I use mouthwash after brushing. While gargling, I was annoyed that every time I screwed the cap back on the bottle of Listerine® (I drink from the cap, yes), a little bit of mouthwash dripped from the cap on the bottle and the shelf, making it all very sticky. The previous bottle of mouthwash I used was Elmex Sensitive. For some of you an unknown brand maybe, but they really did something very clever: they made a little drinking tube inside the cap! Lo and behold, no more mouthwash dripping out, no more sticky bottles!
What does this have to do with dividend investing? Well... nothing really. But it gave me the idea to take a look at the companies behind all those bottles of mouthwash and see how they're doing, dividend-wise. So here we go.

How to invest in a clean taste?
Since this website is about dividend investing, the focus will be on stocks paying out dividend. Luckily, most producers of mouthwash are well-known companies and listed on the New York Stock Exchange: Colgate Palmolive (NYSE: CL), GlaxoSmithKline (NYSE: GSK), Jonhson & Johnson (NYSE: JNJ) and Procter & Gamble (NYSE: PG). All companies except GlaxoSmithKline are also S&P 500 Dividend Aristocrats.

Colgate Palmolive
Colgate Palmolive is owner of the GABA Group, which produces Aronal, Elmex and Meridol mouth-/dental rinses in Therwil, Switzerland. Colgate Palmolive had a net income of USD 2.5 billion in the last 12 months and has paid uninterrupted dividends on its common stock since 1895 and increased payments to common shareholders every year for 48 years.

GlaxoSmithKline
GSK produces mouthwash under the name of Astring-O-Sol, made famous by model Joey Eastwood in the kissing booth TV commercial. GSK had a net income of GBP 3.3 billion (~USD 5 billion) in the last 12 months.
The graphs below show the Earnings Per Share (EPS) and Dividend Per Share of GSK.

GlaxoSmithKline EPS and Dividend per Share Graphs

Jonhson & Johnson
In 2006, Listerine® became a JNJ product with the acquiring of Pfizer Consumer Healthcare. Listerine® Antiseptic was created in 1879, making it the first-ever antiseptic mouthwash. JNJ is the world's sixth-largest consumer health company with a net income of USD 64 billion in the last 12 months. The JNJ stock has seen 49 consecutive years of dividend increases.

Procter & Gamble
Oral-B (since acquiring Gillette in 2005) and Scope are brands of mouthwash made by Procter & Gamble. P&G is the largest consumer goods company with a net income of USD 11.8 billion in 2011 and has paid uninterrupted dividends on its stock since 1890 and increased payments to shareholders every year for 54 years.

Name Dividend growth rate (5 years) EPS growth (5 years)
Colgate Palmolive 12.83% 12.17 USD
GlaxoSmithKline 8.12% -17.22 GBP
Jonhson & Johnson 10.60% 7.35 USD
Procter & Gamble 11.37% 10.18 USD


Disclosure: at the moment of writing, TopYields doesn't own any of the stocks mentioned.
Stock name Dividend Yield
Glaxosmithkline 4.47
Johnson & Johnson 2.93
Procter & Gamble 2.49
Colgate Palmolive 2.38

Articles featuring Glaxosmithkline (GSK):

Lanny's July Dividend Income Summary

We are in the thick of summer everyone! Are the dividends coming in hot and heavy? We will have to see my article below. The market has been volatile lately, as well as dividend increases. Let's see my July dividend income results below. Dividend Income I received a total of $571.18 of dividend income in July. A record July baby and getting closer to $1k for an off month. Additionally, my wife earned $87.24 this month and I am still debating on how to incorporate that into the analysis. I... Read more

Bert's July Dividend Income Summary

Looking back, July was a pretty monumental month for me. My daughter turned four months old, went to an in-home daycare for the first time, Cleveland hosted the MLB All Star Game, and it was my birthday! We talk about milestones on this website a lot. Although it wasn't an investing milestone, my birthday did represent another milestone that I won't talk about. But I am learning quickly that time does fly and things can happen in the blink of an eye. That's why today I am going to reflect on... Read more

5%+ Dividend Yield Portfolio: Grinding Along In 2019 (July 2019 Review)

Musings July 2019 was another month that was hard to predict as the market held its breath for the Fed rate decision. At the risk of sounding like a broken record, I again underperformed the S&P 500 (1.4% vs -0.8%), but this was my first month of splitting directions with the market in a negative way. For me, it is still a battle between my quest for bargains (meaning stocks and markets that have had a hard time of it) versus the market that continues to punish the unloved and froth the... Read more

5%+ Dividend Yield Portfolio: Coping With Existential Dread (May 2019 Review)

Musings May was a particularly weird month in a weird period for the markets (though I suppose that could be said about most times). The furious rally from the December 2018 lows (spurred by the narratives of a cool-headed Fed and Administration) fizzled spectacularly against the realities of extended valuations and partisan politics. Just how bad was it? (My advice is to have a drink before you look at your monthly statement this month - otherwise your tears might water down your... Read more

5%+ Dividend Yield Portfolio: The Number Of Stocks To Own (Apr 2019 Review)

Musings More than any single topic, I get a LOT of comments on my articles about ideal portfolio size (the age old ‘concentration vs. diversification’ debate). This is especially true of my extensive ETF holdings (about 50% of my total assets) where I own small pieces of many hundreds of companies. I suppose I’ve always tended to error towards over-diversification since I’ve internalized the ‘wisdom’ that I was taught as an undergraduate finance major about how diversification is the... Read more